Endometrial hyperplasia risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of endometrial hyperplasia include age>35 years, white race, nulliparity, late menopause, early menarche, tamoxifen therapy, obesity, Lynch syndrome, history of diabetes, gallbladder disease, or thyroid disease, and family history of ovarian, colon, or uterine cancers.<ref name=df>Endometrial Hyperplasia. The American Congress of Obstetricians and Gynecologists. http://www.acog.org/Patients/FAQs/Endometrial-Hyperplasia. Accessedon March 3, 2016.</ref> | |||
==Risk Factors== | ==Risk Factors== | ||
*Common risk factors in the development of endometrial hyperplasia | *Common risk factors in the development of endometrial hyperplasia include the following:<ref name=df>Endometrial Hyperplasia. The American Congress of Obstetricians and Gynecologists. http://www.acog.org/Patients/FAQs/Endometrial-Hyperplasia. Accessedon March 3, 2016.</ref> | ||
**Age | **Age (>than 35 years) | ||
**White race | **White race | ||
**Nulliparity | **Nulliparity | ||
Revision as of 13:28, 4 March 2016
|
Endometrial hyperplasia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Endometrial hyperplasia risk factors On the Web |
|
American Roentgen Ray Society Images of Endometrial hyperplasia risk factors |
|
Risk calculators and risk factors for Endometrial hyperplasia risk factors |
Overview
Common risk factors in the development of endometrial hyperplasia include age>35 years, white race, nulliparity, late menopause, early menarche, tamoxifen therapy, obesity, Lynch syndrome, history of diabetes, gallbladder disease, or thyroid disease, and family history of ovarian, colon, or uterine cancers.[1]
Risk Factors
- Common risk factors in the development of endometrial hyperplasia include the following:[1]
- Age (>than 35 years)
- White race
- Nulliparity
- Late menopause (age > 55)
- Early menarche
- History of diabetes mellitus, gallbladder disease, or thyroid disease
- Obesity
- Tamoxifen therapy
- Family history of ovarian, colon, or uterine cancer
- Lynch syndrome
References
- ↑ 1.0 1.1 Endometrial Hyperplasia. The American Congress of Obstetricians and Gynecologists. http://www.acog.org/Patients/FAQs/Endometrial-Hyperplasia. Accessedon March 3, 2016.